April 21 (Reuters) - DuPont's weak quarterly sales and lowered annual profit forecast provided fresh ammunition to Nelson Peltz in his campaign to win board seats and split up the chemical maker.
Peltz's hedge fund Trian Fund Management, DuPont's fifth-largest shareholder with a 2.7 percent stake, has for months criticized DuPont's underperformance.
Also read: Factors to watch on Jan 17
12:23 Morgan Stanley beats, has a record-breaking quarter for wealth management17
12:23 Sterling volatile as market speculates on ‘hard Brexit’; investors await May's speech15
15:04 Hoping to save a 20 percent down payment? It's a big chunk of change14
13:21 Bank of America profits surge on cost cuts, trading gains25